Cereset logo

COVID Ages the Brain 10 Years

Have you had COVID?   Always feel fatigued?

Have you had COVID?
Always feel fatigued?

Do you think you avoided having post-COVID issues? Maybe, maybe not … If you have any ongoing health and wellness issues, you may have Long COVID and not even know it. (source: Time 2022) New scientific data now shows 1 in 5 Americans who have had COVID still have Long COVID or other post-COVID issues.
(source: National Center for Health Statistics 2022)

Science has studied hundreds of thousands of people infected with COVID and many others who continue to suffer from its ongoing persisting symptoms, often called Long COVID. Research shows COVID directly attacks the brain, leaving long-lasting neurological and physical issues such as brain fog and fatigue.

Your brain may have just aged 7 to 20 years.

For anyone infected by COVID, even if they are not seriously ill, the infection is equivalent to aging the brain by 7 to 10 years. For those that experience COVID with brain fog, it can be equivalent to up to 20 years! Remember, your brain begins shrinking in your 30s or 40s and dramatically increases the shrinkage rate by the time you are in your 60s. COVID highly accelerates this.

Initial symptoms are just the tip of the iceberg. Below the surface, there may be cascading issues that range from … loss of cognitive abilities like brain fog, memory loss, and poor focus/concentration … to psychological problems like anxiety and depression … to physical problems like loss of taste & smell, chronic pain (chest, muscle, joints, headaches), shortness of breath or difficulty breathing, persistent cough, fast or pounding heartbeat, fever, dizziness, insomnia, fatigue and much more. Other health issues may become worse after physical or mental activity.

See what Cereset can do for post Covid brain fog.

Hear what actual Cereset® clients have to say about how our process has helped their memory, cognitive, and metal clarity issues resulting from Covid 19.

Have you lost hope?

Cereset can help.

Cereset is likely to help the brain help itself to gain regulation and lessen or eliminate these long-COVID symptoms since the brain drives the body. A harmonized brain can help itself to likely reverse these harmful and frightening issues caused by COVID. How do you know if your brain is out of harmony? How do you get it back into harmony? Cereset of course … find a center near you!

Cereset can help your brain help you resolve COVID issues.

Most Long COVID symptoms are likely the results of a brain traumatized by the virus. Cereset has developed a new protocol from working with brain data of previously infected COVID clients. Our new protocol can now support the brain to restore itself and lessen the brain’s accelerated aging effects. Cereset has been proven to help relax your brain, so it resets itself to likely mitigate these Long COVID symptoms. Cereset has helped over a hundred thousand others with their health and wellness challenges, as well as been studied in many clinical trials. This is an exciting time for Cereset, and all of the Cereset offices across the country are available to assist you.

Cereset’s patented BrainEcho® technology is non-invasive, safe, proven, and highly effective in helping the brain relax to support brain-driven anti-aging. Cereset helps the brain reset itself to its natural state, restoring rhythm and harmony. Clients typically experience a reduction of symptoms in as little as four to five sessions in less than three weeks.

Science Confirms COVID Can Attack You Any Time After Your COVID Infection

Your brain may be under attack!

Attack leaves long-lasting neurological issues … source: A Sobering Addition to the Literature on COVID-19 and the Brain (Yale University via JCI). Other research found virus levels were over 1,000 times higher in the brain than in the body … source: Neuroinvasion and Encephalitis Following Inoculation of SARS-CoV-2 in K18-hACE2 Mice (Georgia State University via Science Immunology). Cereset has been proven to help reverse this process and protect the brain.

Aging Happens with COVID Infections!

COVID infections age the brain by 7 to 10 years. COVID infections which include the symptom of brain fog, age the brain by 20 years … source: Cognitive Impairment from Severe COVID-19 Equivalent to 20 Years of Aging (University of Cambridge via Neuroscience news). Cereset has an advanced brain-driven anti-aging protocol that can help your brain overcome this accelerated brain aging process.

Experienced Brain Fog? It may be the COVID you just had.

COVID causes cognitive impairment, often experienced as “brain fog”, similar to what goes on with the brain over 50 and 70 years of age and “is the equivalent to losing 10 IQ points” … source: Cognitive Impairment From Severe COVID-19 Equivalent to 20 Years of Aging (University of Cambridge). If you have had any type of cognitive impairment (brain fog or dementia) from COVID, Cereset can help restore your lost IQ AND enable you to recover to a brain capability beyond where you were when COVID began.

Long COVID is caused by the brain.

Long COVID issues experienced in the body are actually driven by the brain … source: How Effects on the Brain Can Produce Long COVID (Yale School of Medicine). Cereset understands that the brain drives the body, and so this is true! Cereset can help as one of the only currently known solutions to the COVID brain problem. 

Our Latest News

Scottsdale, Arizona

Cereset Antiaging™ – a brain-driven antiaging™ solution

The Problem
We spend over $60 Billion each year on antiaging products and services in the USA. Obviously, it is vital that we stay as young as possible (in appearance and health). Yet, the real source of aging – the brain – is not being addressed successfully. Understanding antiaging from the brain’s perspective is critical.
The brain’s cerebral cortex (outer layer) begins to shrink when we are about 30 years of age. As we grow older, the brain shrinks faster, beginning at about age 60, and for those headed toward Alzheimer’s Disease or Dementia, the brain shrinks very fast in some specific areas. (reported by the Center of Lifespan Changes of Oslo, Norway).

Scottsdale, Arizona

Cereset – The Greatest Weapon Against Long COVID and an Aging Brain

COVID has infected over 458 million people around the world. OMICRON – the newest COVID-like virus – has infected over 130 million people globally, is much more infectious, and has a much higher death rate. Science has identified an ongoing issue with all of those who COVID has infected – these infected individuals, even if they do not realize it, have a brain that has become smaller. Any COVID infection is a significant str…

Scottsdale, Arizona

Cereset Efficacy Proven In Relationship to Bio-Functions

It is amazing when we realize that half of us in the US as adults will hear the words – “you have cancer.” One out of two of us will hear these words and will never be the same for the remainder of our life. Each of us has a 50/50 chance to hear it in our lifetime – wow, that is truly significant.
Cancer is a disease that we need to be aware of so we can best understand how to stay healthy, how to resist cancer during the cancer…

Scottsdale, Arizona

Cereset Efficacy Proven In Relationship to Bio-Functions

For over a decade, Cereset and its legacy technology have been confirmed by measuring biological functions to measure efficacy. In everything that has been measured to date, Cereset is shown to have set the gold standard to support the brain’s own correction of many issues.
HRV (heart rate variability) along with BP (blood pressure) has enabled researchers to see the efficacy of Cereset for sleep, PTSD, hot flashes…

References to explore

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study

X. Yang et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 8, 475–481 (2020).

Extrapulmonary manifestations of COVID-19

A. Gupta et al., Extrapulmonary manifestations of COVID-19. Nat. Med. 26, 1017–1032 (2020).

Post-acute COVID-19 syndrome

A. Nalbandian et al., Post-acute COVID-19 syndrome. Nat. Med. 27, 601–615 (2021).

COVID-19: ICU delirium management during SARS-CoV-2 pandemic

K. Kotfis et al., COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit. Care 24, 176 (2020).

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

L. Mao et al., Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA

oroNerve Study Group, Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study

A. Varatharaj et al; CoroNerve Study Group, Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. Lancet Psychiatry 7, 875–882 (2020).

Cerebral micro-structural changes in COVID-19 patients – An MRI-based 3-month follow-up study

Y. Lu et al., Cerebral micro-structural changes in COVID-19 patients – An MRI-based 3-month follow-up study. EClinicalMedicine 25, 100484 (2020).

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study

F. Zhou et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395, 1054–1062 (2020).

Psychosocial factors and hospitalisations for COVID-19: Prospective cohort study based on a community sample

G. D. Batty et al., Psychosocial factors and hospitalisations for COVID-19: Prospective cohort study based on a community sample. Brain Behav. Immun. 89, 569–578 (2020).

Functional and cognitive outcomes after COVID-19 delirium

B. C. Mcloughlin et al., Functional and cognitive outcomes after COVID-19 delirium. Eur. Geriatr. Med. 11, 857–862 (2020).

Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline

P. Pinna et al., Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline. J. Neurol. Sci. 415, 116969 (2020).

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system

. G. De Felice, F. Tovar-Moll, J. Moll, D. P. Munoz, S. T. Ferreira, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the central nervous system. Trends Neurosci. 43, 355–357 (2020).

Detection of severe acute respiratory syndrome coronavirus in the brain: Potential role of the chemokine mig in pathogenesis

J. Xu et al., Detection of severe acute respiratory syndrome coronavirus in the brain: Potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis. 41, 1089–1096 (2005).

Possible central nervous system infection by SARS coronavirus.

K.-K. Lau et al., Possible central nervous system infection by SARS coronavirus. Emerg. Infect. Dis. 10, 342–344 (2004).

Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome

E. C. W. Hung et al., Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin. Chem. 49, 2108–2109 (2003).

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

T. Moriguchi et al., A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 94, 55–58 (2020).

SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis

Y. H. Huang, D. Jiang, J. T. Huang, SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav. Immun. 87, 149 (2020).

Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection

R. Bernard-Valnet et al., Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection. Eur. J. Neurol. 27, e43–e44 (2020).

Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia

L. S. Politi, E. Salsano, M. Grimaldi, Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. 77, 1028–1029 (2020).

Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology

R. R. Reichard et al., Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 140, 1–6 (2020).

Neuropathology of patients with COVID-19 in Germany: A post-mortem case series

J. Matschke et al., Neuropathology of patients with COVID-19 in Germany: A post-mortem case series. Lancet Neurol. 19, 919–929 (2020).

Neuroinvasion of SARS-CoV-2 in human and mouse brain

E. Song et al., Neuroinvasion of SARS-CoV-2 in human and mouse brain. bioRxiv [Preprint] (2020).
https://www.biorxiv.org/content/10.1101/2020.06.25.169946v2 (Accessed 8 November 2020)

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice

F. S. Oladunni et al., Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat. Commun. 11, 6122 (2020).

SARS-CoV-2 infection impacts carbon metabolism and depends on glutamine for replication in Syrian hamster astrocytes

G. de Oliveira et al., SARS-CoV-2 infection impacts carbon metabolism and depends on glutamine for replication in Syrian hamster astrocytes. bioRxiv [Preprint] (2021).
https://www.biorxiv.org/content/10.1101/2021.10.23.465567v1 (Accessed 30 October 2021)

SARS-CoV-2 targets neurons of 3D human brain organoids

A. Ramani et al., SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J. 39, e106230 (2020).

SARS-CoV-2 infects human neural progenitor cells and brain organoids

B.-Z. Zhang et al., SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 30, 928–931 (2020).

COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice

J. Zheng et al., COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature 589, 603–607 (2021).

SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration

L. Zhang et al., SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct. Target. Ther. 6, 337 (2021).

Long Covid: Una nuova sfida oltre l’emergenza

A. Grieco, Long Covid: Una nuova sfida oltre l’emergenza. Come ritrovarebenessere e salute dopo il Covid-19 (Naturvis Books, 2021).

SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids

L. Pellegrini et al., SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell 27, 951–961.e5 (2020).

The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier

T. P. Buzhdygan et al., The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol. Dis. 146, 105131 (2020).

SARS-COV2 alters blood brain barrier integrity contributing to neuro-inflammation

J. L. Reynolds, S. D. Mahajan, SARS-COV2 alters blood brain barrier integrity contributing to neuro-inflammation. J. Neuroimmune Pharmacol. 16, 4–6 (2021).

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

B. Li et al., Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol. 109, 531–538 (2020).

Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses

F. Weber, V. Wagner, S. B. Rasmussen, R. Hartmann, S. R. Paludan, Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80, 5059–5064 (2006).